FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 198 filers reported holding FIBROGEN INC in Q2 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $327,000 | -8.9% | 9,435 | -2.5% | 0.01% | -16.7% |
| Q4 2020 | $359,000 | -48.1% | 9,678 | -42.5% | 0.01% | -53.8% |
| Q3 2020 | $692,000 | +47.2% | 16,819 | +44.9% | 0.01% | +30.0% |
| Q2 2020 | $470,000 | +17.5% | 11,606 | +0.8% | 0.01% | 0.0% |
| Q1 2020 | $400,000 | -20.3% | 11,511 | -1.7% | 0.01% | -9.1% |
| Q4 2019 | $502,000 | +29.4% | 11,716 | +11.6% | 0.01% | +22.2% |
| Q3 2019 | $388,000 | -19.7% | 10,498 | -1.9% | 0.01% | -18.2% |
| Q2 2019 | $483,000 | -8.9% | 10,697 | +9.7% | 0.01% | -8.3% |
| Q1 2019 | $530,000 | +124.6% | 9,752 | +158.9% | 0.01% | +100.0% |
| Q2 2018 | $236,000 | -0.4% | 3,767 | -14.6% | 0.01% | 0.0% |
| Q4 2017 | $237,000 | 0.0% | 4,410 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $237,000 | +253.7% | 4,410 | +112.6% | 0.01% | +200.0% |
| Q2 2017 | $67,000 | -19.3% | 2,074 | -38.7% | 0.00% | 0.0% |
| Q1 2017 | $83,000 | – | 3,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
| ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
| BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
| Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
| Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
| Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
| PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
| Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |